Ascendis Pharma to raise capital with convertible notes
![Photo: Kevin Grønnemann / MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13856869.ece/ALTERNATES/schema-16_9/doc7k9czhj50q81fsr3m4tl.jpg)
Danish biotech firm Ascendis Pharma, which is listed in the US, wants to raise USD 500m by offering convertible notes, the company reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ascendis Pharma reports promising phase III data
For subscribers
Ascendis Pharma initiates clinical trial of dwarfism drug
For subscribers